Former J&J Attorney and Current Kalderos Board Director Says Battle over Rebates Has Not Ended
An influential drug industry expert said that he expects Johnson & Johnson (J&J) to sue the government over its refusal [...]
*Sign up for news summaries and alerts from 340B Report